INTT.AMEXIntest CORP

10-Q/A: inTEST Corporation Restates Q3 2023 Financials Due to Revenue Recognition Error

Sentiment:

Quarterly Report Amendment


inTEST Corporation has filed an amended quarterly report to restate its financial statements for the three and nine months ended September 30, 2023, due to an error in revenue recognition.

Capital raiseThe company issued and sold 921,797 shares of common stock for net proceeds of $19.2 million between May 11, 2023 and May 31, 2023.The company may fund future acquisitions through a combination of cash, credit facility, or by issuing additional equity.
Worse than expectedThe company's financial results were worse than previously reported due to the restatement.The restatement was caused by a material weakness in internal control over financial reporting.The company's revenue and earnings were reduced as a result of the restatement.

Summary

  • inTEST Corporation has restated its unaudited consolidated financial statements for the three and nine months ended September 30, 2023.
  • The restatement was due to the incorrect recognition of revenue related to the sale of discontinued materials/components that were still physically located with the company.
  • Although legal title had transferred to the customer, the company did not meet the requirements for revenue recognition under U.S. GAAP.
  • The restatement resulted in a decrease in revenue of $1.722 million for both the three and nine-month periods.
  • The cost of revenue was also decreased by $835,000 for both periods.
  • Accrued sales commissions were reduced by $72,000 and domestic and foreign taxes payable were reduced by $126,000.
  • The company's management determined the effects of the restatement to be material.

Sentiment

Score: 4

Explanation: The sentiment is negative due to the restatement of financials and the identification of a material weakness in internal controls. However, the company is taking steps to remediate the issues, which provides some hope for improvement.

Positives

  • The company has identified and corrected the error in revenue recognition.
  • The company is taking steps to remediate the material weakness in internal controls.

Negatives

  • The company had to restate its financial statements due to a material error.
  • A material weakness in internal control over financial reporting was identified.
  • The restatement resulted in a reduction of previously reported revenue and earnings.

Risks

  • The company's internal controls over financial reporting were deemed ineffective due to a material weakness.
  • The company's ability to produce timely and accurate financial statements could be impaired if the material weakness is not remediated.
  • The ongoing conflict between Hamas and Israel could disrupt the supply chain for certain components.
  • The company is exposed to risks associated with the war in Ukraine and global supply chain constraints.

Future Outlook

The company anticipates that its cash and cash equivalents, combined with borrowing capacity and operating cash flow, will be sufficient to support short-term working capital and corporate requirements. The company also plans to pursue acquisition opportunities and may fund these through cash, credit facility, or equity.

Management Comments

  • Management determined the effects of the restatement to be material.
  • Management is developing a remediation plan to address the material weakness in internal control over financial reporting.

Industry Context

The company operates in the semiconductor and automated test equipment (ATE) markets, which are known for their cyclical nature. The company is also diversifying into other markets such as automotive, defense/aerospace, industrial, life sciences, and security to reduce its dependence on the semiconductor market. The restatement highlights the importance of robust internal controls in the face of complex revenue recognition rules.

Comparison to Industry Standards

  • The restatement of financial statements due to revenue recognition issues is not uncommon in the technology sector, particularly for companies with complex sales arrangements.
  • Companies like Teradyne and Advantest, which are major players in the ATE market, also face challenges related to revenue recognition and supply chain management.
  • The material weakness identified in internal controls is a concern, and the company's remediation efforts will be closely watched by investors and analysts.
  • The company's diversification strategy is similar to that of other ATE companies seeking to reduce their reliance on the cyclical semiconductor market.

Stakeholder Impact

  • Shareholders will be impacted by the restatement of financial results and the identified material weakness.
  • Employees may be impacted by changes in internal controls and potential supply chain disruptions.
  • Customers may be impacted by potential delays in product shipments due to supply chain issues.

Next Steps

  • The company will implement a remediation plan to address the material weakness in internal control over financial reporting.
  • The company will continue to monitor the situation with its sole-source supplier in Israel.
  • The company will continue to evaluate buying patterns and opportunities for growth in its target markets.

Key Dates

DateDescription
March 29, 2010Date of a lease agreement for a facility in Mt. Laurel, NJ.
October 27, 2010Date of a lease agreement for a facility in Mansfield, MA.
October 15, 2021Date of the original loan agreement with M&T Bank.
October 28, 2021Date the company drew $12 million under the Term Note to finance the acquisition of Videology and entered into an interest rate swap agreement.
December 21, 2021Date of the acquisition of Acculogic.
December 29, 2021Date the company drew $8.5 million under the Term Note to finance the acquisition of Acculogic.
June 23, 2021Date the Employee Stock Purchase Plan was approved by stockholders.
September 20, 2022Date the loan agreement with M&T Bank was amended.
March 8, 2023Date of restricted stock awards to the CEO, CFO and other senior management.
May 8, 2023Date of restricted stock awards to the president of the Environmental Technologies segment.
May 11, 2023Date the company entered into an At-the-Market Issuance Sales Agreement.
June 21, 2023Date the inTEST Corporation 2023 Stock Incentive Plan was approved by stockholders.
August 24, 2023Date restricted stock awards vested at 150%.
September 30, 2023End of the reporting period for the restated financials.
November 9, 2023Date of the original filing of the quarterly report on Form 10-Q.
March 1, 2024Date used to determine the number of outstanding shares of common stock.
March 27, 2024Date of the amended filing of the quarterly report on Form 10-Q/A.
April 30, 2024Expiration date of a letter of credit for a lease in Mt. Laurel, NJ.
December 31, 2024Expiration date of a letter of credit for a lease in Mansfield, MA.
April 30, 2031Extended expiration date of a letter of credit for a lease in Mt. Laurel, NJ.

Keywords

restatement, revenue recognition, internal control, material weakness, financial statements, supply chain, semiconductor, test equipment, financial reporting, component materials

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.